Biocon Limited — Board Meeting, 23-04-2025: Outcome of Board Meeting

Biocon Limited has announced a board meeting outcome highlighting key decisions. The board approved raising funds up to ₹4,500 crores through various methods, including equity shares and non-convertible debt instruments. Additionally, the authorized share capital will be increased from ₹625 crores to ₹700 crores, necessitating a consequent amendment to the Memorandum of Association. Shareholder approval will be sought via a postal ballot, with further details to be communicated soon. These strategic moves aim to bolster the company's financial position and support its growth initiatives.